Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT

We conducted a registry analysis including adult acute myeloid leukemia (AML) patients in remission who had received thiotepa, busulfan, and fludarabine (TBF) or treosulfan-based (Treo) conditioning for haplo-hematopoietic stem cell transplant (HSCT) with posttransplant cyclophosphamide (PTCy) betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraceni, Francesco, Labopin, Myriam, Raiola, Anna M., Blaise, Didier, Reményi, Péter, Sorà, Federica, Pavlu, Jiri, Bramanti, Stefania, Busca, Alessandro, Berceanu, Ana, Battipaglia, Giorgia, Visani, Giuseppe, Sociè, Gerard, Bug, Gesine, Micò, Caterina, La Nasa, Giorgio, Musso, Maurizio, Olivieri, Attilio, Spyridonidis, Alexandros, Savani, Bipin, Ciceri, Fabio, Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513143/
https://www.ncbi.nlm.nih.gov/pubmed/37746158
http://dx.doi.org/10.1097/HS9.0000000000000952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513143/
https://www.ncbi.nlm.nih.gov/pubmed/37746158
http://dx.doi.org/10.1097/HS9.0000000000000952

Ejemplares similares